Genetic profiles and clinical features in subcutaneous panniculitis‐like T‐cell lymphomas
Open Access
- 17 September 2024
- journal article
- research article
- Published by Wiley in Cancer Science
- Vol. 115 (11) , 3788-3794
Abstract
Subcutaneous panniculitis‐like T‐cell lymphoma (SPTCL) is a rare peripheral T‐cell lymphoma characterized by cutaneous lesions and immunologic manifestations. The five‐year survival rate of SPTCL has been reported to be over 80%, indicating a favorable prognosis. Recent studies have uncovered recurrent germline variants in HAVCR2, encoding an immunomodulator. In this study, we integrated whole‐exome sequencing data from 60 samples collected from 36 SPTCL patients, encompassing six patients of our cohort and 30 patients of publicly available data. We identified 138 somatic mutations in skin tumors of 24 patients and HAVCR2 germline mutations in 23 of 29 patients. HAVCR2 p.Tyr82Cys mutations were identified in four of six Japanese patients. During the clinical courses of four patients, cyclophosphamide, hydroxydaunomycin, vincristine, and prednisone were administered to all patients, but it resulted in incomplete responses in all four patients. However, disease conditions of all patients remained stable with additional treatment, including autologous peripheral blood stem cell transplantation. Over a 7.5‐year median follow‐up, one patient developed autoimmune‐related diseases, while one developed other hematological malignancy, resulting in death. To our knowledge, this is the first report of recurrent HAVCR2 germline mutations in Japanese patients, suggesting the necessity for long‐term follow‐up.Keywords
Funding Information
- Japan Society for the Promotion of Science (JP20J20851, JP21K16261, JP23K15293, JP23K15316, JP23K15317)
This publication has 17 references indexed in Scilit:
- igv.js: an embeddable JavaScript implementation of the Integrative Genomics Viewer (IGV)Bioinformatics, 2022
- Variant interpretation using population databases: Lessons from gnomADHuman Mutation, 2021
- Cutaneous lymphoma in Japan, 2012–2017: A nationwide studyJournal of Dermatological Science, 2020
- Subcutaneous panniculitis-like T-cell lymphoma: Clinical features, therapeutic approach, and outcome in a case series of 16 patientsJournal of the American Academy of Dermatology, 2018
- Germline HAVCR2 mutations altering TIM-3 characterize subcutaneous panniculitis-like T cell lymphomas with hemophagocytic lymphohistiocytic syndromeNature Genetics, 2018
- Recurrent mutations in epigenetic modifiers and the PI3K/AKT/mTOR pathway in subcutaneous panniculitis‐like T‐cell lymphomaBritish Journal of Haematology, 2017
- Critical care management of patients with hemophagocytic lymphohistiocytosisIntensive Care Medicine, 2010
- Hemophagocytic syndromesBlood Reviews, 2007
- HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosisPediatric Blood & Cancer, 2006
- A Predictive Model for Aggressive Non-Hodgkin's LymphomaNew England Journal of Medicine, 1993